Recombinant Human IL-10 Prevents the Onset of Diabetes in the Nonobese Diabetic Mouse
The DOI matches its Crossref record.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
Insulin-Dependent Diabetes Mellitus
Tisch, R., & McDevitt, H. (1996) · Cell · doi:10.1016/s0092-8674(00)81106-x · Cited by 1,150
Powrie, F., Leach, M. W., Mauze, S., Menon, S., Barcomb Caddle, L., & Coffman, R. L. (1994) · Immunity · doi:10.1016/1074-7613(94)90045-0 · Cited by 1,146
Interleukin-10 Therapy—Review of a New Approach
Asadullah, K., Sterry, W., & Volk, H. D. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.2.4 · Cited by 946
T Helper Cell Subsets in Insulin-Dependent Diabetes
Katz, J. D., Benoist, C., & Mathis, D. (1995) · Science · doi:10.1126/science.7761837 · Cited by 593
The role of interleukin-1 in the pathogenesis of IDDM
Mandrup-Poulsen, T. (1996) · Diabetologia · doi:10.1007/bf00400649 · Cited by 543
Interleukin-10 Signaling Blocks Inhibitor of κB Kinase Activity and Nuclear Factor κB DNA Binding
Schottelius, A. J. G., Mayo, M. W., Sartor, R. B., & Baldwin, A. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.31868 · Cited by 532
IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation
Park, S.-J., Nakagawa, T., Kitamura, H., Atsumi, T., Kamon, H., Sawa, S.-I., Kamimura, D., Ueda, N., Iwakura, Y., Ishihara, K., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.3844 · Cited by 519
Hammond, K. J. L., Poulton, L. D., Palmisano, L. J., Silveira, P. A., Godfrey, D. I., & Baxter, A. G. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.7.1047 · Cited by 474
Rabinovitch, A., & Suarez-Pinzon, W. L. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00492-9 · Cited by 466
DiLillo, D. J., Matsushita, T., & Tedder, T. F. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05137.x · Cited by 432
Tian, J., Atkinson, M. A., Clare-Salzler, M., Herschenfeld, A., Forsthuber, T., Lehmann, P. V., & Kaufman, D. L. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1561 · Cited by 426
Regulatory B cells as inhibitors of immune responses and inflammation
Bouaziz, J., Yanaba, K., & Tedder, T. F. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00661.x · Cited by 425
Trembleau, S., Penna, G., Bosi, E., Mortara, A., Gately, M. K., & Adorini, L. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.2.817 · Cited by 423
Treg and CTLA-4: Two intertwining pathways to immune tolerance
Walker, L. S. K. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.06.006 · Cited by 411
Hong, E.-G., Ko, H. J., Cho, Y.-R., Kim, H.-J., Ma, Z., Yu, T. Y., Friedline, R. H., Kurt-Jones, E., Finberg, R., Fischer, M. A., et al. (2009) · Diabetes · doi:10.2337/db08-1261 · Cited by 411
Immunosuppressive and Anti-inflammatory Properties of Interleukin 10
de Vries, J. E. (1995) · Annals of Medicine · doi:10.3109/07853899509002465 · Cited by 391
Low Production Capacity of Interleukin-10 Associates With the Metabolic Syndrome and Type 2 Diabetes
van Exel, E., Gussekloo, J., de Craen, A. J. M., Frölich, M., Bootsma-van der Wiel, A., & Westendorp, R. G. J. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1088 · Cited by 358
Calcinaro, F., Dionisi, S., Marinaro, M., Candeloro, P., Bonato, V., Marzotti, S., Corneli, R. B., Ferretti, E., Gulino, A., Grasso, F., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-1831-2 · Cited by 352
Checkpoints in the progression of autoimmune disease: lessons from diabetes models.
André, I., Gonzalez, A., Wang, B., Katz, J., Benoist, C., & Mathis, D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.6.2260 · Cited by 337
The complex role of adipokines in obesity, inflammation, and autoimmunity
Taylor, E. B. (2021) · Clinical Science · doi:10.1042/cs20200895 · Cited by 330
The paradigm of Th1 and Th2 cytokines: Its Relevance to Autoimmunity and Allergy
Singh, V. K., Mehrotra, S., & Agarwal, S. S. (1999) · Immunologic Research · doi:10.1007/bf02786470 · Cited by 318
A Comprehensive Review of Interventions in the NOD Mouse and Implications for Translation
Shoda, L. K. M., Young, D. L., Ramanujan, S., Whiting, C. C., Atkinson, M. A., Bluestone, J. A., Eisenbarth, G. S., Mathis, D., Rossini, A. A., Campbell, S. E., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.08.002 · Cited by 317
COOKE, A., TONKS, P., JONES, F. M., O'SHEA, H., HUTCHINGS, P., FULFORD, A. J. C., & DUNNE (1999) · Parasite Immunology · doi:10.1046/j.1365-3024.1999.00213.x · Cited by 315
Barshes, N. R., Wyllie, S., & Goss, J. A. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.1104649 · Cited by 307
Saxena, A., Khosraviani, S., Noel, S., Mohan, D., Donner, T., & Hamad, A. R. A. (2015) · Cytokine · doi:10.1016/j.cyto.2014.10.031 · Cited by 306
Autoimmune Destruction of Pancreatic β Cells
Yoon, J.-W., & Jun, H.-S. (2005) · American Journal of Therapeutics · doi:10.1097/01.mjt.0000178767.67857.63 · Cited by 308
Current status of interleukin-10 and regulatory T-cells in cancer
Dennis, K. L., Blatner, N. R., Gounari, F., & Khazaie, K. (2013) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000006 · Cited by 289
“had no influence on the disease when given to older animals (memory phase) [93].”
BackgroundChronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling
Cope, A. P., Liblau, R. S., Yang, X.-D., Congia, M., Laudanna, C., Schreiber, R. D., Probert, L., Kollias, G., & McDevitt, H. O. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.9.1573 · Cited by 287
“Systemic IL-10 therapy can delay the onset and reduce the incidence of IDDM in NOD mice (28).”
Molecular mechanisms of interleukin-10-mediated inhibition of NF-κ B activity: a role for p50
DRIESSLER, F., VENSTROM, K., SABAT, R., ASADULLAH, K., & SCHOTTELIUS, A. J. (2003) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2004.02342.x · Cited by 269
The role of IL-12 in the induction of organ-specific autoimmune diseases
Trembleau, S., Adorini, L., Germann, T., & Gately, M. K. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80006-9 · Cited by 263
Th1 and Th2 T helper cell subsets affect patterns of injury and outcomes in glomerulonephritis
Holdsworth, S. R., Kitching, A. R., & Tipping, P. G. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00369.x · Cited by 262
Ko, K. S., Lee, M., Koh, J. J., & Kim, S. W. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0459 · Cited by 97
Metadata
- Authors
- Pennline, K. J., Roque-Gaffney, E., & Monahan, M.
- Venue
- Clinical Immunology and Immunopathology
- Publisher
- Elsevier BV
- Published
- 1994-05
- Volume
- 71
- Issue
- 2
- Pages
- 169-175
- ISSN
- 0090-1229 (ISSN-L)
- OpenAlex
- W2041469322
- Cited by
- 424
- References
- 0
- FWCI
- 14.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.